All reports

The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making

KCE Reports 324C (2019)

Statins for the primary prevention of cardiovascular events

KCE Reports 306C (2019) A healthy lifestyle remains the most effective way of avoiding cardiovascular diseases and their consequences. Yet since 2002, the annual number of people who use cholesterol-lowering drugs from the statin family increased from 400,000 to 1,500,000.

Cardiovascular pre-participation screening in young athletes

KCE Reports 241C (2015)About 1 million young Belgians (14-34) are member of a sportsclub, and in addition, many others are practicing a sport outside the structure of a sport organization. As we all know, sport is very good for your health. But, unfortunately, but luckily very seldom, it can lead to a sudden death due to cardiac failure. The authorities already have made a lot of effort to limit the risk for sporters. But can we avoid this kind of shocking events by submitting young sporters, without heart complaints, to a systematic heart examination?

Revascularization for lower limb peripheral arterial disease

KCE Reports 221C (2014)

General framework for a multidisciplinary quality manual for cardiac care networks

KCE Reports 213C (2013)

Novel serum biomarkers for the prediction of cardiovascular risk

KCE Reports 201C (2013)

Catheter ablation of atrial fibrillation

KCE Reports 184C (2012)

Diagnosis and treatment of varicose veins in the legs

KCE Reports 164C (2011) Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant.

Transcatheter Aortic Valve Implantation (TAVI): a Health Technology Assessment Update

KCE Reports 163C (2011)

Cardiac resynchronisation therapy. A health technology assessment

KCE Reports 145C (2010)

[Statins in Belgium: utilization trends and impact of reimbursement policies]

KCE Reports 141 (2010)

Pacemaker therapy for bradycardia in belgium

KCE Reports 137C (2010)

Remote monitoring for patients with implanted defibrillators. Technology evaluation and broader regulatory framework

KCE Reports 136C (2010)

Percutaneous heart valve implantation in congenital and degenerative valve disease. A rapid Health Technology Assessment

KCE Reports 95C (2008)

64-Slice computed tomography imaging of coronary arteries in patients suspected for coronary artery disease

KCE Reports 82C (2008)

Drug Eluting Stents in Belgium: Health Technology Assessment

KCE Reports 66C (2007)

The Implantable Cardioverter Defibrillator: a Health Technology Assessment

KCE Reports 58C (2007)

[Rapid Assessment: Cardiovascular Primary Prevention in the Belgian General Practice]

Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant. KCE Reports 52 (2007)

[Practice pattern variation in the treatment of acute myocardial infarction in Belgian hospitals]

KCE Reports 14 (2005)

You are here

All reports

General domain

Publication year

Results

19 results

The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making

Statins for the primary prevention of cardiovascular events

Cardiovascular pre-participation screening in young athletes

Revascularization for lower limb peripheral arterial disease

General framework for a multidisciplinary quality manual for cardiac care networks

Novel serum biomarkers for the prediction of cardiovascular risk

Catheter ablation of atrial fibrillation

Diagnosis and treatment of varicose veins in the legs

Transcatheter Aortic Valve Implantation (TAVI): a Health Technology Assessment Update

Cardiac resynchronisation therapy. A health technology assessment

[Statins in Belgium: utilization trends and impact of reimbursement policies]

Pacemaker therapy for bradycardia in belgium

Remote monitoring for patients with implanted defibrillators. Technology evaluation and broader regulatory framework

Percutaneous heart valve implantation in congenital and degenerative valve disease. A rapid Health Technology Assessment

64-Slice computed tomography imaging of coronary arteries in patients suspected for coronary artery disease

Drug Eluting Stents in Belgium: Health Technology Assessment

The Implantable Cardioverter Defibrillator: a Health Technology Assessment

[Rapid Assessment: Cardiovascular Primary Prevention in the Belgian General Practice]

[Practice pattern variation in the treatment of acute myocardial infarction in Belgian hospitals]